Key facts
- Micro Medical Solutions’s last known valuation is $166.6M (Mar 2023).
- It has raised $42.6M across 10 recorded rounds; the latest was Seed Round ($2.3M) in Oct 2025.
- Micro Medical Solutions has filed 14 Form Ds with the SEC since 2014, most recently Nov 2025 ($2.3M sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 10 rounds
- ·Watchlist + deal alerts for Micro Medical Solutions
Funding rounds
10 roundsAbout Micro Medical Solutions
Developer of microvascular intervention therapies designed to reduce the number of preventable amputations. The company's therapies use minimally invasive tools and technology to fight the impact of critical limb ischemia (CLI) to improve clinical outcomes and patient quality of life, enabling physicians to minimize the significant morbidity, mortality, and healthcare burden associated with atherosclerotic disease.
- Sector
- Healthcare
- HQ
- Woburn, MA, United States
- Founded
- 2013
- Employees
- 18
- Website
- micromedicalsolutions.net/
- Ownership
- Privately Held (backing)
Micro Medical Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Micro Medical Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Micro Medical Solutions in its N-PORT filings yet. We sweep new filings monthly.